USPTO serial 97642362
EPIC
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 31, 2024
- Examiner
- CLYBURN, CARLA DIONNE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with EPIC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael J. Leonard
Michael J. Leonard FOX ROTHSCHILD LLP997 LENOX DRIVE, BLDG. 3LAWRENCEVILLE, NJ 08648-2311UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Human immune cells, in particular T cells, for scientific and medical research | ACTIVE | — |
| 005 | Chemical, biological and biochemical preparations and reagents for the cultivation of human immune cells, in particular T cells, for medical purposes in the treatment of immuno-oncological diseases; Human immune cells, in particular T cells, for medical or clinical purposes; biological preparations and pharmaceutical compositions containing human immune cells, in particular T cells for the treatment of immuno-oncological diseases; biological preparations and pharmaceutical preparations for use in medical and clinical cell therapy, in particular immune cell therapy, in particular T cell therapy; biological preparations and pharmaceutical composition containing human immune cells, in particular T-cells, for the treatment of inflammatory diseases, diseases of the immune system and cancer; biological preparations and pharmaceutical preparations containing human immune cells, in particular T-cells, for the treatment of inflammatory diseases, diseases of the immune system and cancer; biological preparations and pharmaceutical preparations in the form of living cells for use in the treatment of immuno-oncological diseases | ACTIVE | — |
| 040 | Contract manufacturing of therapeutic medicinal products, namely, Contract manufacturing of cell therapies for the treatment of inflammatory diseases, diseases of the immune system and cancer; Contract manufacturing for others, in particular manufacturing of pharmaceutical preparations for health care, for the treatment of people suffering from diseases treated by cell therapy or regenerative medicine products, namely, medicinal products for human use including investigational medicinal products, investigational biological products, cell therapy preparations and advanced therapy medicinal products, all of the foregoing not in connection with medical diagnostics, cancer diagnostics and cancer profiling | ACTIVE | — |
| 042 | Development of biological and pharmaceutical medicinal products for the treatment of diseases using a cell therapy platform; all of the foregoing not in connection with medical diagnostics, cancer diagnostics and cancer profiling | ACTIVE | — |
| 044 | Medical services related to the treatment and preparation of human cells; medical services, namely, immune cell therapy; medical services, namely, immune cell modification; medical services, namely, administration of immune cells; medical consulting related to immune cell therapy, all of the foregoing not in connection with medical diagnostics, cancer diagnostics and cancer profiling | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by invIOs GmbH
- Other trademarks owned by invIOs GmbH
- Other trademarks owned by invIOs GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named EPIC
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 31, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 31, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 9, 2024 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Dec 9, 2024 | RG1B | REINSTATEMENT GRANTED - REQUEST TO DELETE 1(B) FILED | — |
| Dec 9, 2024 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 9, 2024 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 7, 2024 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| May 7, 2024 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| May 7, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 12, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 12, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 21, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 21, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 31, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 16, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 16, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 15, 2024 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Nov 29, 2023 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Nov 29, 2023 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Nov 29, 2023 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Nov 29, 2023 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Nov 8, 2023 | OTHE | CASE RETURNED TO EXAMINATION | — |
| Nov 8, 2023 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Oct 3, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 8, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 8, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 19, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 30, 2023 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Jun 23, 2023 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| May 18, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 18, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 18, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 18, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 18, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 26, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 26, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 26, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 10, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 10, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 10, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 31, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 6, 2023 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Jan 5, 2023 | ALIE | ASSIGNED TO LIE | — |
| Nov 8, 2022 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Nov 6, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 25, 2022 | NWAP | NEW APPLICATION ENTERED | — |